Zydus Lifesciences Ltd.

Zydus Lifesciences has informed that meeting of the Board of Directors of the Company will be held on Wednesday, August 10, 2022 to consider, apart from other agenda items, approval of unaudited financial results for the quarter ended on June 30, 2022. The trading window as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed till August 15, 2022 and shall open for trading on and from August 16, 2022 for all the Directors and Designated Persons.

The above information is a part of company’s filings submitted to BSE.